Investigate the Development and Progression of Lung Disease in Rheumatoid Arthritis Over Time

NCT03616158 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 340

Last updated 2019-06-06

No results posted yet for this study

Summary

The purpose of this study is to investigate the link between the lungs and rheumatoid arthritis (RA). Additionally, to understand why RA patients get lung disease, how to treat, and prevent the disease.

Conditions

Sponsors & Collaborators

  • Pfizer

    collaborator INDUSTRY
  • National Jewish Health

    lead OTHER

Principal Investigators

  • Joshua Solomon, MD · National Jewish Health

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-05-10
Primary Completion
2023-05-10
Completion
2024-12-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03616158 on ClinicalTrials.gov